Table 4. Abundant EPS-miRNAs differentially expressed in IIIA CP/CPPS patients compared to healthy men.

EPS-MiRNA	Comparison Group			Health Group H2/H1 Fold	Disease Group P2/P1 Fold
	P3	H3	P3/H3 Fold
miR-30e-5p	729.34	178.10	4.10	0.78	0.21
miR-200a-3p	449.09	142.90	3.14	0.43	0.44
miR-141-3p	14960.17	4929.89	3.03	0.75	0.65
miR-101-3p	1872.78	619.24	3.02	1.44	0.47
miR-30a-5p	7324.17	2460.57	2.98	0.88	0.60
miR-107	1226.86	421.50	2.91	0.59	0.82
miR-98-5p	274.63	103.76	2.65	0.14	0.44
miR-21-5p	7158.38	2744.56	2.61	0.72	0.58
miR-148b-3p	499.68	196.43	2.54	0.59	0.49
miR-103a-3p	1643.27	666.45	2.47	0.75	0.73
miR-10a-5p	4630.96	1899.24	2.44	1.34	0.07
miR-19b-3p	1386.08	577.76	2.40	1.55	0.48
miR-25-3p	730.49	324.84	2.25	1.71	0.49
miR-148a-3p	27642.08	12371.25	2.23	1.33	0.39
miR-203a	296.09	133.90	2.21	0.49	1.45
miR-192-5p	733.45	336.26	2.18	0.46	0.72
let-7f-5p	5786.28	2681.02	2.16	0.18	0.80
miR-30d-5p	1642.32	774.87	2.12	1.03	0.61
miR-183-5p	4414.73	2089.05	2.11	1.20	0.47
miR-363-3p	781.63	372.88	2.10	1.31	0.42
let-7a-5p	7130.00	3514.19	2.03	0.18	0.97
let-7c-5p	1292.39	638.20	2.03	0.19	0.95